This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_RECTOSIGMOID_JUNCTION_EXALLC for full statistics.
Malignant neoplasm of rectosigmoid junction
C3_RECTOSIGMOID_JUNCTION
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
541 |
4. Check minimum number of eventsNone |
541 |
5. Include endpointsNone |
541 |
6. Filter based on genotype QC (FinnGen only) |
541 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of rectosigmoid junction
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)
- Colorectal cancer
- Colorectal cancer, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 541 | 197 | 344 |
| Unadjusted period prevalence (%) | 0.12 | 0.07 | 0.15 |
| Median age at first event (years) | 68.87 | 66.30 | 70.34 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 497
- Matched controls
- 4968
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
+∞
323.0
423
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
565.6
240.9
221
7
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
73.9
193.0
216
51
L01BC06
ATC
capecitabine; oral
50.4
173.5
210
71
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
86.7
164.1
179
32
130
Kela drug reimbursment
Malignant tumour
19.4
159.3
274
296
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
94.2
136.0
147
22
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
15.2
116.2
213
234
UJF32
NOMESCO Finland
Coloscopy
9.2
111.1
338
933
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
48.9
89.4
108
28
A03FA01
ATC
metoclopramide; systemic, rectal
7.3
82.4
255
630
A04AA02
ATC
granisetron; systemic, transdermal
14.0
77.4
141
137
WX302
NOMESCO Finland
Thoracal epidural anesthesy
13.4
74.5
138
138
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
126.5
62.5
66
6
H02AB02
ATC
dexamethasone; systemic
7.4
56.6
152
280
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
12.9
53.0
98
93
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
19.2
51.6
80
49
JN4BD
NOMESCO Finland
Extensive body CT
6.3
51.0
156
338
B01AB05
ATC
enoxaparin; parenteral
4.3
49.8
273
1101
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
29.1
42.2
57
22
JG1BG
NOMESCO Finland
MRI of rectum
73.9
41.8
47
7
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
12.1
39.9
75
72
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
418.8
39.6
39
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.4
39.2
134
320
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.4
38.8
99
162
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
17.2
38.1
61
40
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
44.8
36.9
45
11
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
65.3
36.8
42
7
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
105.6
36.3
39
*
WF001
NOMESCO Finland
Preoperative radiotherapy
29.3
35.7
48
18
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.5
35.1
80
109
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
42.6
34.9
43
11
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
61.9
34.7
40
7
C20
ICD-10 Finland
Malignant neoplasm of rectum
44.6
33.6
41
10
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
51.2
32.0
38
8
JFF23
NOMESCO Finland
Transversostomy
24.6
32.0
45
20
JN4AD
NOMESCO Finland
Body CT examination
5.6
30.9
98
210
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
110.0
29.0
31
*
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
14.3
27.5
47
36
D75
ICPC
Malignant neoplasm colon/rectum
24.1
26.9
38
17
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.5
26.2
64
96
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
53.0
25.5
30
6
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
12.6
25.5
46
40
UJG02
NOMESCO Finland
Proctoscopy
11.4
25.4
48
46
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
13.7
25.4
44
35
8480/3-C19.9
ICD-O-3
Mucinous adenocarcinoma of rectosigmoid junction
+∞
25.2
24
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
24.6
189
852
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
22.0
24.2
35
17
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
9.2
24.0
51
61
JFB54
NOMESCO Finland
Laparoscopic resection of sigmoid colon with partial proctectomy
91.3
23.9
26
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
23.7
211
1040
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
38.4
23.2
29
8
WZC30
NOMESCO Finland
Teaching
3.6
23.1
116
383
JFB46
NOMESCO Finland
Resection of sigmoid colon
18.7
23.0
35
20
JG1CG
NOMESCO Finland
Extensive MRI of rectum
42.3
22.9
28
7
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
+∞
21.0
20
*
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
18.3
20.3
31
18
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
60.1
20.1
23
*
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
207.9
19.7
20
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
11.7
19.5
36
33
B01AB10
ATC
tinzaparin; parenteral
4.4
19.4
74
189
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
5.1
19.2
63
138
TJF80
NOMESCO Finland
Ostomy education
16.7
19.0
30
19
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.4
19.0
42
54
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.4
18.1
48
81
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
7.9
17.8
41
56
WX402
NOMESCO Finland
General anaesthesia
2.9
16.1
108
428
SPAT1125
SPAT
Stoma care and guidance
10.9
15.9
30
29
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
15.9
87
300
Z93
ICD-10 Finland
Artificial opening status
27.3
15.7
21
8
N02AA05
ATC
oxycodone; systemic
2.7
15.4
124
550
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
29.7
15.3
20
7
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
5.7
15.2
44
83
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
24.3
15.2
21
9
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
58.5
14.9
17
*
JAH00
NOMESCO Finland
Laparotomy
6.2
14.5
39
67
JFF10
NOMESCO Finland
Loop enterostomy
16.4
14.0
22
14
Z51.5
ICD-10 Finland
Palliative care
3.6
13.8
64
194
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
21.9
13.4
19
9
K56.7
ICD-10 Finland
Ileus, unspecified
9.4
13.4
27
30
JF2AB
NOMESCO Finland
Colongraphy with X-ray
29.2
13.0
17
6
Z93.3
ICD-10 Finland
Colostomy status
12.0
12.9
23
20
JGB01
NOMESCO Finland
Laparoscopic partial proctectomy and colorectal or coloanal anastomosis
51.4
12.9
15
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.4
12.9
65
211
WX704
NOMESCO Finland
Intubation
3.7
12.8
58
173
D18
ICPC
Change in faeces/bowel movements
8.2
12.8
28
36
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.4
12.5
29
41
A04AA01
ATC
ondansetron; systemic, rectal
3.6
11.9
55
167
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
19.5
11.7
17
9
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
19.5
11.7
17
9
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.8
11.6
49
138
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.7
11.5
50
144
A04AA55
ATC
palonosetron, combinations; systemic
8.2
11.5
25
32
369
Kela drug reimbursment
Regorafenib
35.9
11.3
14
*
B01AB04
ATC
dalteparin; parenteral
3.9
11.2
46
126
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
4.5
11.1
39
92
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.7
11.0
78
317
N02BE01
ATC
paracetamol; systemic, rectal
2.3
11.0
430
3642
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
11.0
133
712
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
15.9
10.9
17
11
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
9.1
10.9
22
25
JN4CD
NOMESCO Finland
Very extensive body CT
4.2
10.7
40
101
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.3
10.6
39
97
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.0
10.5
23
30
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.2
10.4
39
99
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
6.1
10.3
27
46
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
40.9
10.0
12
*
SPAT1262
SPAT
Handing over of treatment supplies
2.2
9.9
119
631
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
56.1
9.7
11
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
56.1
9.7
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.2
9.5
35
87
L01BC59
ATC
trifluridine, combinations; systemic
30.7
9.4
12
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
9.4
57
208
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
9.4
9
*
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
3.7
9.2
40
116
ZX120
NOMESCO Finland
Intravenous
2.7
9.1
64
260
UJF30
NOMESCO Finland
Ileoscopy through colon
2.9
8.9
53
194
E0000UV
ATC
NA
1.8
8.8
188
1235
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
50.9
8.7
10
*
JJB10
NOMESCO Finland
Atypcal resection of liver
28.0
8.5
11
*
6434
FHL
Anterior resection
28.0
8.5
11
*
L01XE21
ATC
[U] regorafenib; oral
91.5
8.4
9
*
WX600
NOMESCO Finland
Single shot through catheter
8.8
8.4
17
20
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
11.0
8.3
15
14
WX725
NOMESCO Finland
Noninvasive ventilation
3.4
8.2
38
117
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.2
8.1
24
48
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
4.5
8.1
27
62
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.9
7.8
31
84
L01BC53
ATC
tegafur, combinations; systemic
25.4
7.6
10
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.9
7.5
44
160
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
7.5
66
303
JFF26
NOMESCO Finland
Sigmoidostomy
30.5
7.2
9
*
176
Kela drug reimbursment
Regorafenib
20.4
7.2
10
5
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
20.4
7.2
10
5
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
20.4
7.2
10
5
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
12.3
7.1
12
10
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
12.3
7.1
12
10
D16
ICPC
Rectal bleeding
5.3
7.0
20
39
A04AD12
ATC
aprepitant; systemic
5.8
6.8
18
32
JAH01
NOMESCO Finland
Laparoscopy
3.7
6.8
28
79
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.1
6.8
25
64
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
40.6
6.8
8
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.0
6.7
20
41
ZXC96
NOMESCO Finland
Robot assisted procedure
5.0
6.7
20
41
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.2
6.7
34
113
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
10.2
6.6
12
12
JFB00
NOMESCO Finland
Partial resection of small intestine
5.3
6.4
18
35
1540A
ICD-9 Finland
Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectosigmoid junction[NEOPL MALIG JUNCT RECTOSIGM,INVASIIVINEN KARSINOOMA]
+∞
6.3
6
*
JFF24
NOMESCO Finland
Laparoscopic transversostomy
27.0
6.2
8
*
JFB43
NOMESCO Finland
Left hemicolectomy
7.8
6.2
13
17
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
5.0
6.1
18
37
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
386
541
22.41
306.31
10.2
4.2
ug/l
24.2
34.2
0.25
347
458
(3022145) Colonoscopy Study observation
216
456
7.22
106.53
1.5
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
120
209
7.09
69.20
5.8
3.5
u/ml
163.6
6784.3
0.78
115
179
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
69
101
7.68
46.03
5.7
3.4
u/ml
59.0
498.8
1.05
61
94
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
390
2316
3.45
37.88
15.8
6.5
umol/l
11.1
12.0
1.10
379
2198
(3024561) Albumin [Mass/volume] in Serum or Plasma
354
2017
3.18
36.26
10.5
4.8
g/l
33.4
34.8
4.25
343
1867
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
349
2002
3.09
34.75
6.1
4.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
124
437
3.38
28.33
2.5
2.2
g/l
0.2
0.2
0.82
118
405
(4035726)
113
399
3.32
25.55
1.4
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
359
2392
2.49
21.97
19.2
9.2
e9/l
3.9
4.2
2.19
325
2099
(3023368) Bacteria identified in Blood by Culture
242
1393
2.33
20.18
5.3
4.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
311
1999
2.31
19.85
10.7
10.9
inr
1.2
1.3
0.96
95
545
(3044640) Blood type and Crossmatch panel - Blood
244
1419
2.31
19.76
3.1
2.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
76
248
3.40
19.25
9.3
9.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
60
168
3.89
19.08
7.8
2.7
g/l
0.2
0.3
0.76
54
62
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
119
518
2.66
18.01
2.9
2.9
umol/l
8.3
10.1
0.38
109
464
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
233
1380
2.21
17.52
3.0
2.5
u/l
53.5
56.5
0.72
220
1280
(3012095) Magnesium [Moles/volume] in Serum or Plasma
144
737
2.30
15.09
6.2
3.3
mmol/l
0.8
0.8
2.04
136
686
(3004789) Transferrin [Mass/volume] in Serum or Plasma
135
680
2.31
14.64
2.0
2.4
g/l
2.3
2.3
0.14
130
627
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
426
3336
2.30
14.24
17.3
7.7
u/l
91.0
80.5
3.20
415
3104
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
129
654
2.28
13.68
1.9
2.5
%
18.9
22.2
2.17
109
551
(3047181) Lactate [Moles/volume] in Blood
48
145
3.54
13.61
9.3
6.9
mmol/l
1.3
1.3
0.05
43
128
(3003396) Base excess in Arterial blood by calculation
116
573
2.30
13.03
8.7
7.1
mmol/l
0.5
1.3
1.45
94
449
(3013826) Glucose [Moles/volume] in Serum or Plasma
358
2666
2.01
13.03
6.6
4.8
mmol/l
7.0
6.8
0.82
353
2509
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
315
2254
1.95
12.77
9.5
6.8
mmol/l
1.2
1.2
3.03
261
1895
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
181
1076
2.03
12.59
3.1
2.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
208
1326
1.92
11.64
7.2
3.4
u/l
34.4
32.9
0.26
200
1263
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
288
2082
1.82
10.49
8.5
5.8
mmol/l
1.2
1.2
1.83
271
1861
(40768804) Tissue Pathology biopsy report
240
1646
1.82
10.37
2.8
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
72
323
2.42
9.94
1.6
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
164
1018
1.88
9.62
1.5
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
46
169
2.88
9.45
2.9
2.4
u/ml
0.3
0.4
0.53
31
93
(3033658) Prothrombin time (PT) actual/Normal
174
1109
1.84
9.35
5.1
3.9
%
89.8
85.6
1.49
174
1088
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
151
921
1.89
9.31
10.0
3.2
mmol/l
2.5
2.5
2.28
141
801
(3015377) Calcium [Moles/volume] in Serum or Plasma
223
1537
1.77
9.18
8.4
3.5
mmol/l
2.3
2.3
0.04
207
1312
(3042936) Bacteria identified in Isolate by Culture
119
686
1.94
8.64
1.9
2.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
72
347
2.24
8.41
8.3
4.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
50
207
2.56
8.17
1.3
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
39
142
2.88
8.15
1.5
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
179
1200
1.73
7.87
2.2
2.1
mg/l
3.6
3.2
0.68
160
1013
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
49
212
2.44
7.31
2.2
2.0
ug/l
2.3
3.0
0.16
44
183
(3018418) pH of Serum or Plasma
193
1366
1.64
6.72
5.4
4.0
ph
7.4
7.4
0.05
49
252
(3000991) Gas panel - Venous blood
72
380
2.03
6.64
6.9
7.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
196
1404
1.62
6.45
4.7
5.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
461
4084
1.87
6.29
29.1
16.6
mg/l
40.5
26.4
6.13
433
3335
(3026008) Bacteria identified in Urine by Culture
195
1406
1.60
6.19
3.8
3.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
348
2896
1.57
5.72
5.2
4.7
e6/l
356.4
3863.1
—
8
58
(3013115) Eosinophils [#/volume] in Blood
268
2112
1.53
5.60
5.2
5.7
e9/l
0.2
0.2
1.53
235
1850
(3006504) Eosinophils/100 leukocytes in Blood
248
1931
1.52
5.43
4.9
5.6
%
2.5
2.9
2.12
235
1799
(3019069) Monocytes/100 leukocytes in Blood
248
1940
1.51
5.26
5.2
6.0
%
9.3
9.0
0.55
233
1812
(3012501) Base excess in Blood by calculation
27
103
2.71
5.23
3.6
4.4
mmol/l
2.2
2.4
0.09
21
67
(3018010) Neutrophils/100 leukocytes in Blood
247
1934
1.51
5.19
4.9
5.6
%
60.5
58.4
1.63
232
1807
(3002030) Lymphocytes/100 leukocytes in Blood
250
1966
1.50
5.13
5.2
5.8
%
23.1
26.2
4.25
232
1822
(3022096) Basophils/100 leukocytes in Blood
241
1885
1.50
5.05
5.0
5.6
%
0.5
0.6
2.03
227
1760
(3003458) Phosphate [Moles/volume] in Serum or Plasma
95
599
1.71
4.99
4.4
5.6
mmol/l
1.1
1.0
0.73
90
548
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
31
130
2.47
4.98
1.7
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
258
2053
1.49
4.94
5.1
5.5
e9/l
0.0
0.0
0.96
223
1767
(40761536) Microorganisms panel - Urine sediment
62
347
1.89
4.84
4.5
4.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
82
501
1.75
4.81
5.4
3.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
260
2080
1.48
4.80
5.1
5.6
e9/l
1.6
1.9
1.82
221
1816
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
45
229
2.05
4.60
2.4
2.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
254
2042
1.46
4.47
5.0
5.5
e9/l
0.6
0.6
0.37
216
1749
(3001122) Ferritin [Mass/volume] in Serum or Plasma
218
1704
1.47
4.43
2.8
2.7
ug/l
128.5
157.0
1.40
204
1545
(3002256) Pathology report gross observation
87
557
1.67
4.30
1.4
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
250
2026
1.43
4.11
5.8
5.4
estimate
0.0
0.0
0.00
57
372
(3035350) Ketones [Presence] in Urine by Test strip
250
2027
1.43
4.09
4.3
4.0
estimate
0.0
0.0
0.00
57
377
(3029937) Albumin [Presence] in Urine by Test strip
153
1131
1.49
4.06
4.6
4.3
estimate
0.0
0.0
0.50
49
357
(3037467) Urinalysis macro (dipstick) panel - Urine
342
2942
1.44
4.01
5.5
4.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
69
424
1.72
3.97
3.0
3.1
ng/l
285.0
232.2
0.34
58
389
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
27
120
2.32
3.87
2.7
2.3
g/l
3.3
3.6
0.47
27
115
(3009261) Glucose [Presence] in Urine by Test strip
250
2056
1.40
3.65
4.4
4.0
estimate
0.0
0.0
0.00
55
360
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
74
2.62
3.58
3.3
2.7
%
57.7
59.7
0.22
19
74
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
70
2.63
3.41
3.0
2.3
e9/l
4.1
4.8
0.71
18
70
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
112
807
1.49
3.31
1.9
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
197
1577
1.39
3.29
4.7
4.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
356
3941
0.72
3.23
4.6
4.8
mmol/l
1.4
1.4
0.71
323
3534
(3023103) Potassium [Moles/volume] in Serum or Plasma
465
4321
1.54
3.08
35.3
19.8
mmol/l
4.0
4.0
0.64
454
4190
(3019550) Sodium [Moles/volume] in Serum or Plasma
464
4310
1.54
3.08
35.3
19.7
mmol/l
139.1
139.6
4.64
454
4181
(3020891) Body temperature
35
190
1.90
3.05
5.1
4.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
22
100
2.25
3.03
3.5
2.4
%
15.0
15.4
—
5
50
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
123
922
1.43
2.95
3.0
4.0
ng/l
82.4
295.8
2.43
97
782
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
41
2.97
2.87
1.0
1.3
nmol/l
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
292
2525
1.34
2.86
3.5
3.3
u/l
75.2
55.4
1.97
271
2327
(3007853) Bacteria identified in Skin by Aerobe culture
77
530
1.53
2.83
1.7
1.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
24
117
2.10
2.81
2.5
2.0
%
84.5
87.7
0.23
24
109
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
168
0.29
2.74
1.0
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
66
444
1.55
2.69
3.4
3.6
mmol/l
2.0
1.9
0.10
52
353
(3007566) Smooth muscle Ab [Titer] in Serum
21
99
2.17
2.68
1.1
1.2
—
54.0
—
0
5
(3021447) Carbon dioxide [Partial pressure] in Venous blood
66
446
1.55
2.64
3.4
3.6
kpa
5.5
5.8
1.43
66
432
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
15
4.71
2.60
1.3
3.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
376
4083
0.74
2.57
5.1
5.4
mmol/l
2.6
2.6
0.05
343
3670
(3044889) 12 lead EKG panel
340
3034
1.32
2.54
4.8
4.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
103
768
1.42
2.53
2.5
2.0
s
29.8
29.8
0.02
97
739
(3013707) Erythrocyte sedimentation rate by Westergren method
346
3099
1.32
2.50
3.7
4.2
mm/h
16.3
13.6
1.73
315
2813
(3041096) Erythrocytes [Presence] in Urine by Automated
139
1093
1.37
2.50
4.6
3.8
—
—
—
0
0
(4281824)
11
39
2.86
2.49
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
39
2.86
2.49
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
110
835
1.40
2.44
4.5
4.9
—
—
—
0
0
(3026782) Osmolality of Urine
124
962
1.37
2.42
3.4
3.1
mosm/kgh2o
536.8
562.4
0.72
114
819
(3002619) Bacteria identified in Specimen by Culture
5
8
6.30
2.37
1.0
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
349
3810
0.76
2.31
4.2
4.3
mmol/l
1.3
1.3
0.26
318
3401
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
38
592
0.61
2.23
4.2
4.8
%
32.0
32.0
0.01
29
384
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
36
2.81
2.21
1.0
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
20
101
2.02
2.18
3.9
4.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
368
3975
0.77
2.12
4.6
4.8
mmol/l
4.5
4.4
0.33
337
3596
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
98
753
1.37
2.02
1.2
1.2
u/ml
2.0
1.6
0.18
19
196
(3007461) Platelets [#/volume] in Blood
469
4445
1.41
2.02
46.3
24.5
e9/l
250.7
238.7
2.72
455
4308
(3024731) MCV [Entitic volume]
469
4445
1.41
2.02
46.1
24.4
fl
91.1
91.7
1.48
461
4355
(3035941) MCH [Entitic mass]
469
4445
1.41
2.02
46.0
24.4
pg
30.1
30.5
3.37
461
4354
(3026361) Erythrocytes [#/volume] in Blood
469
4446
1.41
2.00
46.2
24.5
e12/l
4.3
4.4
11.49
454
4292
(3010813) Leukocytes [#/volume] in Blood
469
4446
1.41
2.00
46.3
24.5
e9/l
6.9
6.9
0.29
454
4293
(3000963) Hemoglobin [Mass/volume] in Blood
469
4447
1.41
1.99
46.5
24.6
g/l
127.0
134.2
18.47
460
4352
(3002582) Erythrocytes [#/volume] in Urine
173
1450
1.28
1.94
4.4
3.5
e6/l
91.8
122.5
0.17
141
1144
(3000850) Epithelial cells [#/volume] in Urine
126
1014
1.32
1.91
3.0
2.7
e6/l
6.1
4.3
0.80
117
888
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
65
2.18
1.89
1.1
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
65
2.18
1.89
1.4
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
76
567
1.40
1.88
1.9
1.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
46
2.42
1.86
2.1
2.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
198
1697
1.26
1.84
4.2
3.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
12
4.19
1.82
1.6
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
73
2.08
1.82
2.0
2.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
37
240
1.58
1.81
1.4
1.8
g/l
1.9
1.5
1.44
32
209
(36304419) Bacteria [Presence] in Urine
150
1248
1.28
1.77
4.1
3.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
41
2.47
1.76
1.3
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
22
125
1.79
1.74
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
125
1.79
1.74
1.1
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
70
523
1.39
1.72
1.4
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
381
3535
1.26
1.70
32.0
18.0
%
37.4
39.0
1.95
215
2260
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
44
623
0.68
1.68
1.3
1.3
iu/ml
103.2
38.8
0.90
16
189
(3002385) Erythrocyte distribution width [Ratio]
355
3270
1.25
1.68
40.9
20.5
%
14.8
13.9
13.84
350
3196
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
89
1118
0.76
1.63
1.6
1.7
mmol/l
1.4
1.3
0.37
73
928
(42529406) Shigella sp [Presence] in Stool by Culture
22
128
1.75
1.63
1.1
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
412
3867
1.27
1.62
30.2
15.6
ml/min/173m2
75.7
74.6
0.57
348
3205
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
14
3.59
1.62
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
14
3.59
1.62
1.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
26
2.71
1.58
1.4
2.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
50
2.22
1.58
1.0
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
454
4319
1.32
1.57
20.4
11.2
u/l
24.7
25.2
0.29
445
4135
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
57
2.13
1.56
1.2
2.8
—
915.4
—
0
5
(3027945) Reticulocytes/100 erythrocytes in Blood
77
595
1.34
1.55
2.2
2.5
%
2.0
1.8
0.27
71
531
(40758558) Short blood count panel - Blood
125
1036
1.27
1.51
14.9
6.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
73
564
1.34
1.48
1.8
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
28
2.52
1.45
4.0
4.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
22
2.75
1.44
1.3
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
22
2.75
1.44
1.3
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
154
1317
1.24
1.41
4.4
3.3
e6/l
0.4
0.5
0.31
121
1009
(3048689) Calprotectin [Mass/mass] in Stool
54
401
1.39
1.40
1.4
2.1
ug/g
186.1
140.7
0.38
42
319
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
9
40
2.27
1.40
1.6
1.1
nmol/l
1.5
1.7
—
9
35
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
29
2.43
1.39
1.3
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
441
4198
1.27
1.39
30.8
15.9
—
—
—
0
0
(3013512) EKG study
164
1416
1.23
1.37
3.9
4.3
—
—
—
0
0
(3004451) EKG impression Narrative
6
23
2.63
1.37
1.0
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
35
241
1.48
1.36
1.1
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
11
54
2.06
1.33
1.2
1.4
u/ml
54.2
103.5
—
5
11
(3018095) Leukocytes [#/volume] in Urine
187
1643
1.21
1.31
5.2
3.9
e6/l
238.3
142.0
0.45
145
1213
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
43
2.11
1.31
1.0
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
34
235
1.48
1.30
1.3
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
24
2.52
1.30
1.0
1.3
nmol/l
179.3
132.6
—
6
24
(3026493) Urate [Moles/volume] in Serum or Plasma
98
1181
0.79
1.29
2.9
2.8
umol/l
5189.2
8497.1
0.29
85
998
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
48
2.10
1.28
1.0
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
204
1814
1.20
1.25
18.4
10.1
e9/l
0.0
0.0
0.14
169
1483
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
63
1.93
1.23
1.2
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
180
1.53
1.23
1.7
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
210
1875
1.20
1.23
3.8
4.0
ng/l
44.4
59.0
0.34
173
1439
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
44
587
0.73
1.23
1.2
1.3
u/ml
36.0
13.0
0.61
14
219
(3019832) Treponema pallidum Ab [Presence] in Serum
7
142
0.49
1.22
1.4
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
19
2.65
1.22
3.2
5.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
57
439
1.33
1.20
2.1
2.7
e9/l
78.4
69.6
0.40
39
352
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
6
26
2.32
1.19
1.0
1.0
mg/l
237.8
292.3
—
6
21
(3021901) Oxygen saturation in Capillary blood
16
95
1.71
1.15
3.9
2.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
80
1.77
1.14
1.4
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
102
1204
0.81
1.11
2.9
3.2
ug/l
1.1
0.8
0.53
77
824
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
188
1675
1.19
1.11
2.3
2.2
nmol/l
76.4
78.3
0.35
172
1452
(3043410) Blood group antigens tested for on Red Blood Cells
5
21
2.39
1.09
1.4
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
368
3877
0.84
1.08
6.7
6.5
mmol/mol
41.3
40.9
0.36
334
3554
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
52
1.94
1.06
4.0
2.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
113
964
1.22
1.06
3.8
3.8
—
—
—
0
0
(1002224) Polysomnography panel
6
125
0.47
1.05
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
106
1.62
1.04
1.5
1.7
—
—
—
0
0
(3036603) Volume of Urine
5
22
2.28
1.03
2.2
1.5
—
1734.8
—
0
5
(3025130) Human papilloma virus identified in Specimen
5
22
2.28
1.03
1.6
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
155
1.51
1.02
1.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
118
1016
1.21
1.01
1.7
1.8
pmol/l
378.6
11786578.8
0.79
97
823
(3019150) Specific gravity of Urine by Refractometry
108
922
1.21
1.01
4.2
4.4
kg/l
1.0
1.0
0.44
16
146
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
107
1.61
1.00
1.2
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
29
0.00
0.98
0.0
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
28
199
1.43
0.97
1.7
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
108
1.59
0.97
1.4
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
40
304
1.34
0.95
3.6
3.4
g/l
124.2
127.6
0.41
40
299
(4024509)
0
32
0.00
0.95
0.0
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
107
1237
0.83
0.95
3.3
3.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
384
4013
0.85
0.93
4.8
5.0
mmol/l
6.2
6.1
0.73
346
3592
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
45
350
1.31
0.92
4.2
2.8
ml/min/173m2
63.6
60.3
0.27
21
149
(40760888) Immunoglobulin light chains.free panel - Serum
18
118
1.54
0.92
1.8
4.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
83
697
1.23
0.92
1.6
1.4
g/l
2.9
2.7
0.24
47
416
(3017181) Myelocytes/100 leukocytes in Blood
46
360
1.30
0.91
3.4
4.4
%
1.7
0.8
1.31
24
122
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
15
228
0.65
0.88
1.3
1.4
—
38.4
—
0
17
(3030981) Hyaline casts [#/volume] in Urine by Automated count
36
274
1.34
0.86
3.8
3.0
e6/l
0.4
0.3
0.23
36
268
(3024354) Oxygen [Partial pressure] in Venous blood
48
381
1.29
0.86
3.5
2.8
kpa
4.5
4.3
0.44
48
366
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
31
1.95
0.84
1.2
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
31
1.95
0.84
1.2
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
163
1.43
0.83
1.1
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
90
774
1.20
0.79
4.7
3.1
e6/l
1.8
1.8
0.01
45
459
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
48
1.68
0.79
1.0
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
21
148
1.44
0.79
4.4
5.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
14
90
1.57
0.79
1.0
1.1
—
13.0
—
0
8
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
5
96
0.52
0.78
1.4
1.2
mmol/l
3.5
3.8
—
5
88
(3008898) HLA-B27 [Presence]
5
96
0.52
0.78
1.2
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
26
0.00
0.78
0.0
2.2
—
7.4
—
0
18
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
3.8
—
37.4
—
0
7
(4027681)
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
47
379
1.26
0.76
1.2
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
67
1.66
0.75
1.8
2.0
pg
30.1
33.3
0.66
11
67
(21494815) CD4 cells/100 lymphocytes in Specimen
5
24
2.09
0.74
1.0
1.8
—
32.4
—
0
5
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
55
1.65
0.74
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
195
0.66
0.73
1.3
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
6
108
0.55
0.73
1.3
1.2
mg/l
314.8
489.7
—
6
100
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
60
1.68
0.72
1.3
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
84
1.56
0.72
1.8
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
109
1.48
0.71
1.4
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
58
1.56
0.70
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
85
1.54
0.69
4.3
2.9
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
28
1.79
0.66
1.0
1.3
promille
1.6
1.3
—
5
21
(3000012) Reticulocyte production index
5
28
1.79
0.66
1.0
2.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
17
120
1.43
0.65
3.8
2.4
kpa
7.9
7.7
0.24
17
104
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
38
307
1.26
0.63
1.8
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
105
0.57
0.62
1.2
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
55
466
1.20
0.59
5.1
4.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
11
162
0.67
0.59
1.1
1.1
titre
—
30.2
—
0
6
(4010399)
24
309
0.77
0.59
1.2
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
114
0.61
0.58
1.0
2.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
131
1193
1.13
0.57
1.7
1.6
nmol/l
17.8
20.3
1.41
118
998
(3045414) Leukocytes [Presence] in Urine
12
171
0.69
0.55
1.6
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
161
1487
1.12
0.55
4.3
4.0
mg/mmol
15.7
10.1
0.76
109
954
(3021879) Hepatitis B virus core Ab [Presence] in Serum
28
223
1.27
0.53
1.1
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
66
1.52
0.53
1.4
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
99
0.60
0.52
1.8
2.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
64
1.41
0.51
1.2
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
65
1.39
0.51
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
91
816
1.14
0.50
4.4
2.9
e6/l
0.9
1.1
0.38
46
494
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
13
179
0.72
0.50
2.4
2.2
ug/l
485.6
698.3
0.25
13
169
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
93
1.41
0.48
1.1
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.1
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
47
1.50
0.47
1.7
2.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
84
0.59
0.46
1.0
1.2
—
1.0
—
0
7
(3021440) Promyelocytes/100 leukocytes in Blood
40
339
1.19
0.45
3.4
4.5
%
0.4
0.1
0.77
19
113
(3026389) Candida sp identified in Specimen by Organism specific culture
7
51
1.38
0.44
1.1
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
38
322
1.19
0.44
2.6
4.3
%
0.6
0.5
0.25
13
90
(3009508) Creatinine [Moles/volume] in Urine
153
1428
1.10
0.43
3.4
3.1
mmol/l
7.0
7.5
0.76
130
1173
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
161
0.74
0.41
1.2
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.1
—
36.2
—
0
8
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
15
0.00
0.41
0.0
1.2
—
31.1
—
0
9
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
9.1
—
0
17
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
5.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
(4015189)
0
18
0.00
0.40
0.0
3.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
101
0.69
0.40
2.1
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
215
0.78
0.39
2.5
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
148
0.74
0.39
1.2
1.6
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
3.4
—
30.2
—
0
14
(3037522) Nuclear Ab [Titer] in Serum
42
482
0.86
0.38
1.2
1.3
titre
897.1
437.9
—
7
116
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
29
243
1.20
0.38
6.0
4.1
%
51.1
46.2
0.52
29
238
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
71
1.27
0.36
1.3
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
134
1428
0.92
0.35
1.9
2.1
u/l
184.8
266.9
0.46
123
1325
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
80
0.62
0.35
1.2
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.8
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.8
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.8
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
63
568
1.12
0.34
1.1
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
73
1.38
0.34
1.3
1.5
—
—
—
0
0
(4034850)
10
133
0.75
0.34
10.7
11.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
16
199
0.80
0.34
1.1
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
86
0.69
0.33
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
143
0.76
0.32
6.1
3.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
83
1.33
0.32
1.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
203
1946
1.07
0.30
2.2
2.1
pmol/l
83.7
93.7
3.14
139
1026
(3019230) Fractional oxyhemoglobin in Venous blood
10
76
1.32
0.28
1.2
1.6
%
61.4
58.3
—
10
76
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
64
1.25
0.27
1.1
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
75
0.66
0.26
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
205
1975
1.06
0.26
2.4
2.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
35
312
1.13
0.24
3.1
3.7
mmol/l
1.7
1.9
0.10
20
237
(40768800) Prostate Pathology biopsy report
11
136
0.80
0.23
1.4
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
38
1.32
0.23
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
40
362
1.11
0.23
1.2
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
200
1.16
0.22
1.2
1.2
iu/ml
99.0
124.4
—
7
75
(3022689) Creatine [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
8.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
1799.2
—
0
10
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
141.8
—
0
12
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
6.4
—
0.7
—
0
12
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
89
1.24
0.21
1.5
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
32
288
1.12
0.20
1.5
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
14
0.00
0.20
0.0
1.1
—
3.3
—
0
14
(3029075) Extractable nuclear Ab panel - Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
49
453
1.09
0.19
2.1
2.6
ug/l
9.4
7.0
0.22
39
397
(21494434) Karyotype in Bone marrow
6
52
1.16
0.19
1.2
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
102
972
1.06
0.19
1.9
1.8
nmol/l
1311.9
1201.4
0.44
85
726
(3000330) Specific gravity of Urine by Test strip
22
248
0.88
0.18
6.2
4.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
60
1.17
0.18
1.1
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
35
320
1.10
0.17
3.5
4.5
%
0.0
0.1
0.78
12
96
(3022621) pH of Urine by Test strip
27
299
0.90
0.17
3.0
2.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
73
690
1.07
0.17
24.1
26.6
inr
1.5
1.4
0.36
20
92
(3044941) Cell count panel - Synovial fluid
7
63
1.11
0.17
1.4
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
38
412
0.92
0.17
3.8
3.0
g/l
64.5
66.2
0.52
33
371
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
141
0.85
0.16
1.5
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
6
78
0.77
0.15
1.5
1.5
g/l
30.1
31.4
—
6
68
(3022313) Gas panel - Capillary blood
27
245
1.11
0.15
2.0
3.7
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
6
79
0.76
0.15
4.0
1.9
pmol/l
182.7
217.2
—
6
73
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
83
1.21
0.15
1.3
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
145
1405
1.04
0.15
3.5
3.2
mg/l
73.7
259.2
1.36
103
921
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
93
1.19
0.14
1.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
21
233
0.90
0.14
3.0
2.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
163
1586
1.04
0.14
2.5
3.1
ng/l
1255.1
1611.4
0.99
142
1380
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
9
107
0.84
0.13
2.4
1.9
nmol/l
38.7
44.5
—
9
100
(3037756) Immunofixation for Serum or Plasma
9
109
0.82
0.13
1.7
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
94
907
1.04
0.12
1.8
1.6
mg/l
1.9
1.4
0.63
77
716
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(4306422)
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
73
0.82
0.07
3.0
2.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
74
1.08
0.07
2.5
3.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
38
363
1.05
0.07
1.5
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
24
255
0.94
0.07
2.3
2.9
e9/l
4.5
4.1
0.26
19
181
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
89
1.13
0.07
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
37
385
0.96
0.06
3.2
3.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
141
0.92
0.05
2.8
2.6
ug/min
319.7
94.9
—
8
86
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
100
1.10
0.05
1.1
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
12
130
0.92
0.04
1.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
130
1.08
0.04
1.5
1.6
—
—
—
0
0
(4094501)
10
109
0.92
0.04
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
170
1685
1.01
0.03
4.8
4.6
%
22.8
21.5
0.63
106
844
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
58
569
1.02
0.03
13.7
7.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
296
2974
0.99
0.02
3.8
3.6
pmol/l
14.9
15.0
0.11
272
2622
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
371
3697
1.01
0.02
4.4
4.5
mu/l
2.1
2.0
1.21
340
3275
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
36
351
1.03
0.02
1.4
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
123
1.06
0.01
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
123
1.06
0.01
1.3
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
43
438
0.98
0.01
1.3
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
95
1.05
0.00
1.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
95
1.05
0.00
1.1
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
185
0.97
0.00
2.1
2.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
136
1.03
0.00
1.5
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
97
1.03
0.00
1.3
2.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
34
345
0.98
0.00
3.6
2.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
192
0.99
0.00
4.0
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
192
0.99
0.00
4.0
2.5
g/l
4.4
3.7
0.96
13
138
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
192
0.99
0.00
4.0
2.5
g/l
8.6
7.3
1.96
13
143
(3015171) Extractable nuclear Ab [Units/volume] in Serum
12
119
1.01
0.00
1.2
1.2
—
2.5
—
0
11
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
35
351
1.00
0.00
1.5
1.6
%
1.6
1.6
0.32
27
294
(3000492) Spirometry study
35
351
1.00
0.00
1.4
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
43
431
1.00
0.00
1.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
209
2089
1.00
0.00
4.9
5.4
ug/l
3.7
3.7
0.01
184
1839
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
8.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
16.4
—
0
6
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4146454)
5
54
0.93
0.00
2.0
2.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
58
0.86
0.00
1.0
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
77
0.91
0.00
1.0
1.6
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
59
0.85
0.00
1.0
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
80
1.00
0.00
1.3
1.4
—
—
—
0
0
(44790048)
5
52
0.96
0.00
2.2
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
6
66
0.91
0.00
3.2
1.7
mu/l
351.3
266.3
—
6
60
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806118)
5
52
0.96
0.00
2.2
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
51
0.98
0.00
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
56
0.89
0.00
1.0
1.5
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(44790049)
5
52
0.96
0.00
2.2
1.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
5.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
54
0.93
0.00
1.6
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
57
0.88
0.00
1.6
1.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
13.7
—
6.5
—
0
7
(44790047)
5
52
0.96
0.00
2.2
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
7.7
—
0
6
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
79
0.88
0.00
1.1
1.2
u/l
52.0
49.1
—
7
66
(3024471) HLA-A [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
2.0
1.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
8
0.00
0.00
0.0
9.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
21.6
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
39.1
—
0
7
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
58
0.86
0.00
1.0
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
58
0.86
0.00
1.0
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
6
59
1.02
0.00
1.2
1.8
g/l
2.7
0.9
—
6
46
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
7.2
—
0
6
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
58
0.86
0.00
1.0
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RECTOSIGMOID_JUNCTION – Malignant neoplasm of rectosigmoid junction
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).